Skip to main content Accessibility help
×
Home

Label-free Electrochemical Impedance Detection of Ovarian Cancer Markers CA-125 and CEA

  • Allison M Whited (a1), Kanwar V Singh (a2), Raj Solanki (a3) and David R Evans (a4)

Abstract

CA-125 and carcinoembryonic antigen (CEA) are two biomarkers present in blood that can indicate the presence of ovarian cancer. They can also be used, both in conjunction with each other and independently, to determine the effectiveness of the treatment being meted for the disease. A label-free multiplexed interdigitated electrode array (IDEA) immunosensor was developed to detect both CA-125 and CEA in buffer solution at levels typically seen in patients with ovarian cancer . Electrochemical impedance spectroscopy was used to measure the increase in impedance when a binding event occurred between the target antigen and its specific antibody that was anchored to the surface of an interdigitated electrode array. CA-125 was detected in concentrations as low as 10units/mL and as high as 80units/mL. CEA was detected in concentrations as low as 1pg/mL and as high as 10μg/mL.

Copyright

References

Hide All
1 Gizeli, E. and Lowe, C. R. Current Opinion in Biotechnology, 7(1), 6671 (1996).
2 Sadik, O.A. Aluoch, A.O. and Zhou, A. Biosens. Bioelectron. 24, 27492765 (2009).
3 Wang, J. Biosens. and Bioelectron. 21, 18871892 (2006).
4 Heller, A. Acc. Chem. Res. 23, 128 (1990).
5 Gpel, W. and Heiduschka, P. Biosens. Bioelectron. 10, 853 (1995).
6 Zhong, C.-J. and Porter, M. D. Anal. Chem. 67, 709A (1995).
7, 8, 9. Bourdillon, C. Demaille, C. Gueris, J. Moiroux, J. and Savéant, J.-M., J. Am. Chem. Soc. 115, 12264 (1993); 116, 10328 (1994); 29, 529 (1996)
10 Rogers, K. R. Mol. Biotechnol. 14, 109 (2000).
11 Yang, M. McGovern, M. E. and Thompson, M. Anal. Chim. Acta 346, 259 (1996).
12 Willner, I. Katz, E. Willner, B. Electroanalytical Methods of Biological Materials, ed. Brajter-Toth, A., Chambers, J. Q.. (Marcel Dekker, New York, 2002) p. 43.
13 Campbell, C. N. Gal, D. Cristler, N. Banditrat, C. and Heller, A. Anal. Chem. 74, 158 (2002).
14 Bardea, A. Katz, E. Bückmann, A. F., and Willner, I. J. Am. Chem. Soc. 119, 9114 (1997).
15 Anzai, J. Takeshita, H. Kobayashi, Y. Osa, T. and Hoshi, T. Anal. Chem. 70, 811 (1998).
16 Willner, I. Rubin, S. and Cohen, Y. J. Am. Chem. Soc. 115, 4937 (1993).
17 Suri, C. R. Boro, R. Nangia, Y. Gandhi, S. Sharma, P. Wangoo, N. Rajesh, K. and Shekhawat, G. S., Trends Anal. Chem. 28(1), 29 (2009).
18 Kharitonov, A.B. Alfonta, L. Katz, E. and Willner, I. Electroanal. Chem. 487, 133 (2000).
19 Dharuman, V. Grunwald, T. Nebling, E. Albers, J. Blohm, L. and Hintsche, R. Biosens. Bioelectron. 21, 645 (2005).
20 Valera, E. Ramon-Azcon, J., Rodriguez, A. Castener, L. M. Sanchez, F.-J. and Marco, M.-P. Sensors and Actuators B 125, 526 (2007)
21 Brewood, G. P. Rangineni, Y. Fish, D. J. Bhandiwad, A. S. Evans, D. R. Solanki, R. and Benight, A., Nucl. Acids Res. 36: e98 (2008)
22 Bard, A. J. and Faulkner, L. R. Electrochemical Methods: Fundamentals and Applications (Wiley, New York, 1980).
23 Stoynov, Z. B. Grafov, B. M. Savova-Stoynova, B. S., and Elkin, V. V. Electrochemical Impedance (Nauka, Moscow, 1991).
24 Randles, J. E. B. Discuss Faraday Soc. 1, 11 (1947).
25 Ershler, B. V. Discuss Faraday Soc. 1, 269 (1947).
26Gynecologic Neoplasms at Merck Manual of Diagnosis and Therapy Professional Edition.
27 Goff, B. A. Mandel, L. Muntz, H.G. and Melancon, C.H. Cancer 89 (10): 2068 (2000).
28Survival rates based on SEER incidence and NCHS mortality statistics, as cited by the National Cancer Institute.
29General information about ovarian epthelial cancer, as cited by the National Cancer Institute.
30 Gold, P. Freedman, S.O. J. Exp. Med. 121:439 (1965).
31 markers, Tumor, as cited by the American Cancer Society.
32 Killard, AJ, in The Encyclopedia of Analytical Chemistry, edited by Myers, R. A. (John Wiley & Sons Ltd., New York, 2000) pp. 173207.
33 Katz, E. and Willner, I. Electroanalysis 15, 913947 (2003).

Keywords

Related content

Powered by UNSILO

Label-free Electrochemical Impedance Detection of Ovarian Cancer Markers CA-125 and CEA

  • Allison M Whited (a1), Kanwar V Singh (a2), Raj Solanki (a3) and David R Evans (a4)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.